HomeCompareFFFDX vs JNJ

FFFDX vs JNJ: Dividend Comparison 2026

FFFDX yields 5.39% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FFFDX wins by $8.5K in total portfolio value
10 years
FFFDX
FFFDX
● Live price
5.39%
Share price
$15.37
Annual div
$0.83
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.5K
Annual income
$761.21
Full FFFDX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FFFDX vs JNJ

📍 FFFDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFFFDXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FFFDX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FFFDX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFFDX
Annual income on $10K today (after 15% tax)
$458.46/yr
After 10yr DRIP, annual income (after tax)
$647.03/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $56.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFFDX + JNJ for your $10,000?

FFFDX: 50%JNJ: 50%
100% JNJ50/50100% FFFDX
Portfolio after 10yr
$24.3K
Annual income
$794.50/yr
Blended yield
3.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FFFDX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFFDX buys
0
JNJ buys
0
No recent congressional trades found for FFFDX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFFFDXJNJ
Forward yield5.39%3.36%
Annual dividend / share$0.83$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.5K$20.0K
Annual income after 10y$761.21$827.78
Total dividends collected$6.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FFFDX vs JNJ ($10,000, DRIP)

YearFFFDX PortfolioFFFDX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,239$539.36$10,676$355.77+$563.00FFFDX
2$12,593$566.55$11,407$389.39+$1.2KFFFDX
3$14,067$593.24$12,198$426.53+$1.9KFFFDX
4$15,671$619.36$13,056$467.62+$2.6KFFFDX
5$17,413$644.85$13,987$513.12+$3.4KFFFDX
6$19,302$669.64$14,998$563.56+$4.3KFFFDX
7$21,347$693.71$16,098$619.52+$5.2KFFFDX
8$23,558$717.01$17,295$681.69+$6.3KFFFDX
9$25,947$739.52$18,599$750.82+$7.3KFFFDX
10$28,524$761.21$20,022$827.78+$8.5KFFFDX

FFFDX vs JNJ: Complete Analysis 2026

FFFDXStock

The fund invests in a combination of Fidelity® domestic equity funds, international equity funds (developed and emerging markets), bond funds, and short-term funds. It uses an asset allocation strategy that becomes increasingly conservative until it reaches an allocation similar to that of the Fidelity Freedom® Income Fund (approximately 17% in domestic equity funds, 7% in international equity funds, 46% in bond funds, and 30% in short-term funds (approximately 10 to 19 years after the year 2020)).

Full FFFDX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FFFDX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFFDX vs SCHDFFFDX vs JEPIFFFDX vs OFFFDX vs KOFFFDX vs MAINFFFDX vs ABBVFFFDX vs MRKFFFDX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.